Schley, Katharina https://orcid.org/0000-0002-0975-4154
Heinrich, Kirstin
Moïsi, Jennifer C.
Häckl, Dennis
Obermüller, Dominik
Brestrich, Gordon
von Eiff, Christof
Weinke, Thomas
Funding for this research was provided by:
Pfizer Pharma GmbH (Germany) and Pfizer Inc
Article History
Received: 22 July 2024
Accepted: 31 October 2024
First Online: 20 November 2024
Declarations
:
: Katharina Schley, Gordon Brestrich, and Christof von Eiff are employees of Pfizer Pharma GmbH; Kirstin Heinrich is an employee of Pfizer Inc; and Jennifer C. Moïsi is an employee of Pfizer Vaccines—all of whom may hold stock or stock options in Pfizer Inc. Dennis Häckl is an employee of WIG2, which received funding from Pfizer in connection with the development of this manuscript. Dominik Obermüller is an employee of InGef, which acted as subcontractor and received funding from WIG2 in connection with the development of this manuscript. Thomas Weinke received an honorarium from Pfizer in connection with the development of the study.
: Additional ethics approval was not required as the data were anonymized, and the study, which was a retrospective analysis of an anonymized health claims research database, complied with German data protection regulations and federal law.